Correlation Between Tcr2 Therapeutics and Passage Bio

Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tcr2 Therapeutics and Passage Bio, you can compare the effects of market volatilities on Tcr2 Therapeutics and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Passage Bio.

Diversification Opportunities for Tcr2 Therapeutics and Passage Bio

-0.53

Correlation Coefficient

Tcr2 Therapeutics  Passage Bio

Excellent diversification

The 3 months correlation between Tcr2 and Passage is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Passage Bio go up and down completely randomly.

Pair Corralation between Tcr2 Therapeutics and Passage Bio

If you would invest  70.00  in Passage Bio on August 30, 2024 and sell it today you would lose (3.34) from holding Passage Bio or give up 4.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	1.59%
Values	Daily Returns

Tcr2 Therapeutics  vs.  Passage Bio

Tcr2 Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tcr2 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tcr2 Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Passage Bio

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Passage Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Passage Bio may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Tcr2 Therapeutics and Passage Bio

The main advantage of trading using opposite Tcr2 Therapeutics and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.

The idea behind Tcr2 Therapeutics and Passage Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.